These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 97755)

  • 41. Letter: Unsuitability of blood-donors for population genetics.
    Saugstad LF
    Lancet; 1975 Mar; 1(7905):530-1. PubMed ID: 47008
    [No Abstract]   [Full Text] [Related]  

  • 42. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program.
    Vege S; Westhoff CM
    Immunohematology; 2006; 22(3):143-7. PubMed ID: 17105364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt.
    Abdelrazik AM; Elshafie SM; Ezzat Ahmed GM; Abdelaziz HM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2940-4. PubMed ID: 23362929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What constitutes adequate routine Rh typing on donors and recipients?
    Spielmann W; Allen FH; Engelfriet CP; Freiesleben E; Greenwalt TJ; Huestis DW; Myhre BA; Salmon C
    Vox Sang; 1971 Aug; 21(2):183-92. PubMed ID: 5000960
    [No Abstract]   [Full Text] [Related]  

  • 45. Solid-phase ABO grouping and Rh typing.
    Sinor LT; Rachel JM; Beck ML; Bayer WL; Coenen WM; Plapp FV
    Transfusion; 1985; 25(1):21-3. PubMed ID: 3918360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens.
    Mak KH; Yan KF; Cheng SS; Yuen MY
    Transfusion; 1993 Apr; 33(4):348-51. PubMed ID: 8480357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A "NEW" RH ANTIBODY (ANTI-RH 26) WHICH DETECTS A FACTOR USUALLY ACCOMPANYING HR'.
    HUESTIS DW; CATINO ML; BUSCH S
    Transfusion; 1964; 4():414-8. PubMed ID: 14242756
    [No Abstract]   [Full Text] [Related]  

  • 49. [ABO AND RH (D) BLOOD GROUPS OF BLOOD DONORS OF THE D'EPARTEMENT DU VAR].
    ANDRE LIARDET J; MOULLEC J; NGUYENVAN CONG
    Transfusion (Paris); 1965; 8():31-6. PubMed ID: 14294193
    [No Abstract]   [Full Text] [Related]  

  • 50. [Specificity of antibodies obtained during immunization of Rh-negative blood donors with erythrocytes of Rho (cDe) group].
    Sakharov RS; Piskunova TM; Chubsheva MD; Azovskaia SA
    Probl Gematol Pereliv Krovi; 1974 Apr; 19(4):28-34. PubMed ID: 4209009
    [No Abstract]   [Full Text] [Related]  

  • 51. [The erythrocyte phenotype in ABO and Rh blood groups in blood donors and blood recipients in a hospital setting of Cameroon: adapting supply to demand].
    Tagny CT; Fongué VF; Mbanya D
    Rev Med Brux; 2009; 30(3):159-62. PubMed ID: 19642486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Another example of phenotype Rh.
    Senhausr DA; Mitchell MW; Gault DB; Owens JH
    Transfusion; 1970; 10(2):89-92. PubMed ID: 4191820
    [No Abstract]   [Full Text] [Related]  

  • 53. Red cell antibody screening with the Groupamatic system. I. Bromelin methyl-cellulose and saline techniques: evaluation of five years' routine use.
    Garretta M; Gener J; de Jerphanion I; Jacquet D; Muller A
    Vox Sang; 1979; 37(1):55-61. PubMed ID: 115156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computers and automated technical procedures in blood transfusion laboratories.
    Bird GW
    Rev Fr Transfus Immunohematol; 1978 Mar; 21(2):575-87. PubMed ID: 97760
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular basis of D variants between Uigur and Han blood donors in Xinjiang.
    Li Q; Ye LY; Guo ZH; Zhang YX; Wang LL; Zhu ZY
    Transfus Med; 2008 Jun; 18(3):199-203. PubMed ID: 18598284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.
    El Housse H; El Wafi M; Ouabdelmoumene Z; Zarati F; Alid R; Nourichafi N; Bouisk K; Benajiba M; Férec C; Fichou Y; Habti N
    Blood Transfus; 2019 Mar; 17(2):151-156. PubMed ID: 30418133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of an IgG2, G2m(23) anti-Rh-D antibody.
    Dugoujon JM; de Lange GG; Blancher A; Alie-Daram S; Marty Y
    Vox Sang; 1989; 57(2):133-6. PubMed ID: 2506693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [External national quality control of blood group typing 1983-92. Significance for quality assurance in transfusion medicine].
    Heier HE; Kornstad L
    Tidsskr Nor Laegeforen; 1993 Oct; 113(25):3155-8. PubMed ID: 8273042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ABO and Rh blood group genotypes in a cohort of Saudi stem cell donors.
    Alzahrani M; Jawdat D; Alaskar A; Cereb N; Hajeer AH
    Int J Immunogenet; 2018 Apr; 45(2):63-64. PubMed ID: 29441679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. THE RHO VARIANT--DU. 3. A FIELD TRIAL OF THE DU TUBE TEST IN TYPING DONOR BLOODS.
    PITTENGER RG; MCQUISTON D; STURGEON P
    Transfusion; 1964; 4():361-6. PubMed ID: 14205856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.